Respiratory diseases are a leading cause of death globally. Conditions that affect the lungs, such as asthma and COPD, can be caused by both genetics or contagions.
Challenges of respiratory disease
The nature of respiratory disease, both genetic and contagious, means that drug research faces specific challenges. For those developing effective drugs for inhalation, increased safety and efficacy requirements are routinely faced compared to other types of therapeutic area.
Based in a single-site facility our in-house, multi-disciplinary, teams are well placed to combine their expertise on respiratory disease projects. From discovery, through to efficacy and safety analysis, our focus is on delivering optimal compounds.
Assays available to support respiratory projects include:
- Ion channels
Download our eBook on developing effective assays: